The line dividing biotechnology and high tech is blurring as drug companies find new ways to apply computer advances in the hunt for new drugs. Relay Therapeutics uses these techniques to better understand a protein’s role in disease and develop a drug to address it. Cancer is Relay’s first target. The Cambridge, MA, biotech is […]
Original Article: Relay Raises $400M to Kick Protein Motion Drug R&D into High Gear